跳至主要内容
临床试验/CTRI/2022/11/047446
CTRI/2022/11/047446尚未招募2/3 期

Randomised Controlled Clinical Trial Of Add-on Effect Of Vardhaman Pippali Rasayana On Vidangadi Loha In Management Of Pandu.

Tilak Ayurved Mahavidyalaya Pune1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2022年11月23日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Improvement in PANDUTA, DOURBALYA, SHIRASHOOLA, SHWAS ,HRIDSPANDAN, ARUCHI, AKSHIKOOTA, SHOTH, PINDIKODWESHTAN, BHRAMA, RUKSHATA, GAURAVA, SHRAMA, Hb% ,RBC, MCV, MCH, MCHC and TIBC

研究概览

简要总结

One of the specialities of Ayurvedais the rasayana karma mentioned in it. Diseases like Pandu are not only causedby some dietary causes but it is majorly impacted by the person’s nutritionhence while treating Pandu, only the disease curing (Vyadhi pratyanik chikitsa)strategy does not help but supplemental help (Rasayana Chikitsa) to prolong itseffect is also very much necessary. Hence here in case of Pandu Vidangadi lohacan be used to treat the basic cause of the disease but to get better resultsin the management of the disease subject will be given supplemental meaningRasayan vidhi to prolong its effect. And Pippali’s rasayana karma can bestudied through this in Pandu. Vardhaman Pippali Rasayana is explained bySharangdhar in his texts in Madhyam khanda, as useful in treating Pandu Vyadhiby its Rasayana, Deepana & Pachana, Raktvardhak, Raktashodhak property. Itis also mentioned in Charak Samhita for the same. Hence, this is an attempt toevaluate the efficacy of Vardhaman Pippali Rasayana on the basis of subjectiveand objective parameters.

women of age group of 15 to 49 years. Intervention drug is administered with primary outcome of improvement in clinical signs and symptoms of Pandu andimprovements in laboratory parameters and changes in quality of life as secondary outcome. Assesments aredone at baseline and after 21 days of treatment and patients are followed up for a period of 1 months aftercompletion of treatment for any recurrence of the signs and symptoms. As per the study protocol sufficientnumber of subjects has been registered and recruitment is complete.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
15.00 Year(s) 至 49.00 Year(s)(—)
性别
Female

入选标准

  • The presence of symptoms of Pandu as described in classical Ayurvedic texts such as Panduta, Dourbalya, Shirshoola, Shwasa, Hridaspandan, Aruchi, Akshi koota shotha, Pindikoudveshthan, Bhrama, Rukshata, Gourava and Shrama.
  • Women of reproductive age group of 15-49 years 3)Patients having history of Hb% <12 g% (Female) , low mean corpuscular volume (MCV) (<80 fl); serum iron <50 µg/dl, total iron binding capacity (TIBC) >360 µg/dl.

排除标准

  • Patients having history of Haemoglobin <7 gm% 2)Patients suffering from haematological disorders such as sickle-cell anaemia and thalassemia are excluded.
  • Patients having history of systemic disorders such as uncontrolled hypertension, uncontrolled diabetes mellitus, AIDS, and cancer.
  • Pregnant females and lactating mothers.
  • Gynaecological diseases like Menorrhagia and Obstetric disorders leading to blood loss 6)Grishma and Sharad Ritu.

结局指标

主要结局

Improvement in PANDUTA, DOURBALYA, SHIRASHOOLA, SHWAS ,HRIDSPANDAN, ARUCHI, AKSHIKOOTA, SHOTH, PINDIKODWESHTAN, BHRAMA, RUKSHATA, GAURAVA, SHRAMA, Hb% ,RBC, MCV, MCH, MCHC and TIBC

时间窗: baseline,10th day, 21st day

次要结局

  • to study the adverse effects of Vardhaman Pippali rasayan, if any(21 days)

研究者

发起方
Tilak Ayurved Mahavidyalaya Pune
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验